Renalytix AI plc (RENX) - Cash Flow Conversion Efficiency

Latest as of December 2024: 4.746x

Based on the latest financial reports, Renalytix AI plc (RENX) has a cash flow conversion efficiency ratio of 4.746x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-6.50 Million ≈ $-790.50 USD) by net assets (GBX-1.37 Million ≈ $-166.57 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Renalytix AI plc - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Renalytix AI plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Renalytix AI plc balance sheet liabilities for a breakdown of total debt and financial obligations.

Renalytix AI plc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Renalytix AI plc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Global Partner Acq Corp NASDAQ:GPACU	0.297x
Landore Resources Plc LSE:LND	-1.772x
OCA Acquisition Corp NASDAQ:OCAXU	-0.003x
TAURUS GOLD CORP. F:W1N	N/A
DOLPHIN DRILL. A.S. NK 10 F:L33	N/A
Green Leaf Innovations Inc. NASDAQ:GRLFD	N/A
G2Power Co. Ltd. KQ:388050	-0.043x
ANGLE plc LSE:AGL	-0.385x

Annual Cash Flow Conversion Efficiency for Renalytix AI plc (2012–2025)

The table below shows the annual cash flow conversion efficiency of Renalytix AI plc from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see Renalytix AI plc (RENX) total market value.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	GBX-7.00 Million ≈ $-851.70	GBX-17.90 Million ≈ $-2.18K	2.557x	-33.30%
2024-06-30	GBX-7.85 Million ≈ $-955.60	GBX-30.11 Million ≈ $-3.66K	3.834x	+744.54%
2023-12-31	GBX20.76 Billion ≈ $2.53 Million	GBX9.43 Billion ≈ $1.15 Million	0.454x	+125.64%
2023-06-30	GBX18.45 Million ≈ $2.25K	GBX-32.67 Million ≈ $-3.98K	-1.771x	-67.09%
2022-06-30	GBX43.17 Million ≈ $5.25K	GBX-45.74 Million ≈ $-5.57K	-1.060x	-309.13%
2021-06-30	GBX95.10 Million ≈ $11.57K	GBX-24.63 Million ≈ $-3.00K	-0.259x	+7.42%
2020-06-30	GBX35.96 Million ≈ $4.38K	GBX-10.06 Million ≈ $-1.22K	-0.280x	-97.30%
2019-06-30	GBX28.17 Million ≈ $3.43K	GBX-3.99 Million ≈ $-485.95	-0.142x	-100.32%
2018-06-30	GBX-9.39K ≈ $-1.14	GBX-422.00K ≈ $-51.35	44.946x	+11298.75%
2016-12-31	GBX17.87 Billion ≈ $2.17 Million	GBX7.05 Billion ≈ $857.42K	0.394x	-6.04%
2015-12-31	GBX17.47 Billion ≈ $2.13 Million	GBX7.33 Billion ≈ $891.85K	0.420x	+30.71%
2014-12-31	GBX17.26 Billion ≈ $2.10 Million	GBX5.54 Billion ≈ $674.42K	0.321x	+4.07%
2013-12-31	GBX20.40 Billion ≈ $2.48 Million	GBX6.29 Billion ≈ $765.80K	0.308x	-28.02%
2012-12-31	GBX21.03 Billion ≈ $2.56 Million	GBX9.01 Billion ≈ $1.10 Million	0.429x	--

About Renalytix AI plc

LSE:RENX UK Health Information Services

Market Cap

$95.71K

GBX786.63 Million GBX

Market Cap Rank

#30995 Global

#1119 in UK

Share Price

GBX1.80

Change (1 day)

+0.00%

52-Week Range

GBX1.80 - GBX10.75

All Time High

GBX1220.00